Komori
Governance4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

Report on Corporate Governance 2026/06/24

The corporate governance structure comprises three committees—the Nomination Committee, Compensation Committee and Audit Committee—under the Board of Directors. Representative Executive Officers and Executive Officers conduct business operations, while the Board of Directors provides oversight.

Worth reading
100Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with Three Statutory Committees
Committee5
Nomination CommitteeCompensation CommitteeAudit CommitteeSustainability Committeeand Risk Management and Compliance Committee. Proportion of external committee members: not disclosed
Governance structure
ItemDetails
Corporate Governance StructureCompany with Three Statutory Committees
CommitteeNomination Committee, Compensation Committee, Audit Committee, Sustainability Committee, and Risk Management and Compliance Committee. Proportion of external committee members: not disclosed
Items this document does not state (6)
Number of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The corporate governance structure is presented in a diagram, but no reason is given for adopting or changing this structure on this occasion.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on Corporate Governance 2026/06/24 | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori